Advertisements



Amarin CEO believes Vascepa well positioned to help "millions of patients"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

Amarin"s Vascepa showed "encouraging results" in Covid patients, says Piper

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2020

Amarin"s stock surges, as rival drugs from AstraZeneca, Acasti disappoint

Shares of Amarin Corp. PLC rose 4.8% in active afternoon trading Monday, after makers of drugs that rival Amarin's Vascepa, which is used to lower the risk of cardiovascular events in patients with high triglyc.....»»

Category: topSource: marketwatchJan 13th, 2020

Amarin Reports Second Quarter 2019 Financial Results and Operational Update

Record Total Revenue of $100.8 Million Achieved in Q2 2019 Commercial Expansion Plans on Track in Anticipation of September 28, 2019 PDUFA Date for Vascepa® If Approved, Vascepa to Become First Prescription Therapy to Treat Patients with Underlying Cardi.....»»

Category: earningsSource: benzingaJul 31st, 2019

42 Stocks Moving In Monday"s Mid-Day Session

Gainers Amarin Corporation plc (NASDAQ: AMRN) shares jumped 232.4 percent to $9.94 after the company's REDUCE-IT cardiovascular study of Vascepa in LDL-C patients met its primary endpoint. read more.....»»

Category: blogSource: benzingaSep 24th, 2018

Oxford Secretly Used Millions Of Patients" Cell Phone Data For Vaccine "Mobility Study"

Oxford Secretly Used Millions Of Patients' Cell Phone Data For Vaccine 'Mobility Study' In a flagrant violation of patients' medical privacy that has just come to light, the British government h.....»»

Category: smallbizSource: nytMay 24th, 2021

Why Impact of ‘Long Covid’ Could Outlast the Pandemic

Millions of people who have gotten Covid-19 and survived are finding that a full recovery can be frustratingly elusive. Weeks and months after seemingly recovering from even a mild case, many patients confront a wide range of health problems. A.....»»

Category: topSource: washpostApr 14th, 2021

Amarin"s Vascepa Recommended By Canadian Cardiovascular Society For Prevention Of Cardiovascular Diseases

HLS Therapeutics Inc announced the Canadian Cardiovascular Society had included ic read more.....»»

Category: blogSource: benzingaMar 29th, 2021

Amarin provides update on Vascepa regulatory processes in China, Hong Kong

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 9th, 2021

Scotiabank Believes Diamondback Energy Is "Well-Positioned To Return To E&P Glory"

Despite outperforming the E&P sec.....»»

Category: blogSource: benzingaFeb 1st, 2021

Amarin expands Vascepa patent infringement suit to include Health Net

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 26th, 2021

Cantor says Amarin opportunity for Vascepa outside U.S. still "underappreciated"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 25th, 2021

The Daily Biotech Pulse: Fluidigm"s Saliva-Based COVID Test Approved In Europe, China Backs Amarin"s Vascepa

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) read more.....»»

Category: blogSource: benzingaJan 22nd, 2021

Durham drugmaker ends Covid-19 program despite millions in federal funding

A Triangle company that had been awarded tens of millions worth of federal contracts to study its drug's potential for treating Covid-19 patients says it's ending those efforts......»»

Category: topSource: bizjournalsJan 2nd, 2021

Amarin rises following "encouraging" results in COVID patients

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2020

Amarin says Vascepa reduced Covid inflammation by 25% in early study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2020

Amarin announces presentation of Vascepa findings at conference

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 14th, 2020

40 Under Forty: Dr. Kartik Antani traveled to Mexico to help dental patients in need

Antani believes a true professional is someone who responds to their surrounding community and culture beyond their job or career......»»

Category: topSource: bizjournalsMay 15th, 2020

Why an Appeals Court May Hold Key to Amarin Stock Future

Amarin Corp. PLC (NASDAQ: AMRN) plans to mount a vigorous and speedy appeal of a U.S. District Court ruling that blocked its patents on the medication Vascepa, the company’s chief executive says. In........»»

Category: blogSource: 247wallstMay 8th, 2020

Hospitals are losing millions of dollars per day amid the pandemic

Conservative estimates indicate that U.S. hospitals are losing more than a billion dollars per day by complying with the guidance from policymakers and the leading medical associations to preserve resources for COVID-19 patients......»»

Category: personnelSource: nytMay 5th, 2020

Hospitals are losing millions of dollars per day amid the pandemic

Conservative estimates indicate that U.S. hospitals are losing more than a billion dollars per day by complying with the guidance from policymakers and the leading medical associations to preserve resources for COVID-19 patients......»»

Category: personnelSource: nytMay 5th, 2020